102 Alternatively, several teams are advocating for the incorporation of novel markers, such as a elaborate karyotype55 or epigenetic subsets, 27,28 into clinical observe. All of these novel prognostic and/or predictive designs will need to be validated in cohorts of people addressed with focused ag